The Texas Medical Center has been identified as a key partner for a national health-focused initiative. TMCx has been selected as one of eight accelerator programs to be a part of the program that focuses on identifying emerging health security threats, according to a release from TMC.
The United States Department of Health and Human Services has provided TMCx a $96,500 to conduct research and provide solutions for two different challenges within mitigating these risks.
"The first is 'pre-symptomatic' detection of illness, or detecting illness in patients and suggesting treatment before they even begin to show symptoms," the release reads. "The second is addressing sepsis, a life-threatening reaction to infection."
Sepsis, which is one of the most costly illnesses hospitals treat, affects 1.7 million patients a year.
HHS' Biomedical Advanced Research and Development Authority, or BARDA, has a new entity called DRIVe, which stands for Division of Research, Innovation, and Ventures. The effort will be lead by the new organization, which comes at a result of the 21st Century Cures Act that was enacted to spur health security within technology.
In July, HHS officials toured the TMC Innovation Institute campus before deciding to work with the accelerator. TMCx is no stranger to the national spotlight. In November, the organization was lauded for its accelerator program with a national award.
The accelerator has announced its eighth cohort of startups this spring. The 21 companies will be focused on digital health. Last cohort, TMCx accelerated 23 companies that raised $73 million by demo day.
In December, Erik Halvorsen, who had lead the Innovation Institute for a few years, abruptly left his position as director. Lance Black, associate director of TMCx, has been named the interim director.